Category survey

Using Global Positioning System (GPS) Technologies for Safer Walking: A participative inquiry project Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

The Arts in Dementia – TAnDem Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

Researching Patient Safety & Risk enablement Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

The PREVENT Project Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

Transdisciplinary training for dementia research in CFAS Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

Computational models of neurodegenerative disease progression Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

Zero-Field MRI to Enhance Diagnosis of Neurodegeneration Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

Quantification of vascular and neuronal pathology in dementia using PET and MRI Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

Multi-modal retinal biomarkers for vascular dementia: developing enabling image analysis tools Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

Computational PLatform for Assessment of Cognition In Dementia (C-PLACID) Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

Multimarker Parkinson’s Diagnotic test kit for monitoring disease progression based on electroanalytical detection of protein changes in blood. Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

MODEM – Monitoring Of Dementia using Eye Movements Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

A device to detect and measure the progression of dementia by quantifying the interactions between neuronal and cardiovascular oscillations Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

Novel Point-of-Care Diagnostic Techniques for Dementia Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

OCEAN: One-stop-shop microstructure-sensitive perfusion/diffusion MRI: Application to vascular cognitive impairment Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

Simultaneous PET-MR Modelling and Reconstruction for Imaging Brain Disorders Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

EPSRC Centre for Predictive Modelling in Healthcare Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

Alzheimer’s Research UK Drug Discovery Institute 2015: University College London Investments > €500k United Kingdom Neurodegenerative disease in general 2016    

Alzheimer’s Research UK Drug Discovery Institute 2015: University of Oxford Investments > €500k United Kingdom Neurodegenerative disease in general 2016    

Determining the causes and consequences of brain amyloidosis, atrophy and cerebrovascular disease Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

Research into early-onset dementia Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

Alzheimer’s Research UK Drug Discovery Institute 2015: University of Cambridge Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

Alzheimer’s Research UK Stem Cell Research Centre Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

Alzheimer’s Research UK Drug Discovery Institute 2016: University of Cambridge Investments > €500k United Kingdom Neurodegenerative disease in general 2016    

Alzheimer’s Research UK Drug Discovery Institute 2016: University of Oxford Investments > €500k United Kingdom Neurodegenerative disease in general 2016    

Alzheimer’s Research UK Drug Discovery Institute 2016: University College London Investments > €500k United Kingdom Neurodegenerative disease in general 2016    

Endoplasmic reticulum-mitochondria interactions and Alzheimer’s disease Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

Targeting perivascular innervation and vascular tone for improved clearance of ß-amyloid from the brain Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

Hypertension, hypoperfusion and neurodegeneration in Alzheimer’s disease Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

Targeting tau to prevent Abeta mediated synapse degeneration in Alzheimer’s Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

Pharmacological modulation of CSF1R activation to control microglial proliferation in Alzheimer’s disease Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

Mechanisms of neurodegeneration in an animal model of cerebral hypofusion Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

An Investigation of the role of the ageing process in Alzheimer’s Disease Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

The role of Dkk1 in Amyloid-beta mediated effects on dendritic spines and long-term depression Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

123I-MIBG Scintigraphy Utility as a biomarker for Prodromal DEmentia with Lewy Bodies (SUPErB) Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

Imaging amyloid and neuroinflammation in subjects “at risk” for Alzheimer’s disease Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

‘A randomized controlled trial of calcium channel blockade (CCB) with amlodipine for the treatment of subcortical ischaemic vascular dementia (SIVD). (AFFECT clinical trial). Investments > €500k United Kingdom Alzheimer’s disease & other dementias 2016    

Family traits of chronic disease and the missing heritability link. The Malmö Offspring Study (MOS) Investments > €500k Sweden Alzheimer’s disease & other dementias 2016    

Mental and cognitive health in relation to functional ability and somatic health in the elderly. The influence of age, sex, birth cohort, genetic, psychological, social and neurobiological factors. Investments > €500k Sweden Alzheimer’s disease & other dementias 2016    

ALS as a Model System for Studying Degenerative Brain Diseases Investments > €500k Sweden Motor neurone diseases 2016    

Maintaining Neuronal Identity – Transcriptional control of the aging brain Investments > €500k Sweden Parkinson’s disease & PD-related disorders 2016    

Novel Biomarkers for Alzheimer’s disease to improve early diagnosis and development of novel therapies Investments > €500k Sweden Alzheimer’s disease & other dementias|Parkinson’s disease & PD-related disorders 2016    

Theoretical and empirical aspects of aging and rejuvenation Investments > €500k Sweden Alzheimer’s disease & other dementias 2016    

Molecular imaging in neuropathology Investments > €500k Sweden Alzheimer’s disease & other dementias|Parkinson’s disease & PD-related disorders 2016    

Wearable sensors in smart textiles Investments > €500k Sweden Parkinson’s disease & PD-related disorders 2016    

Forte-centre: FAS center KI-SU ARC (Karolinska Institutet – Stockholm University Aging Research Center) Investments > €500k Sweden Alzheimer’s disease & other dementias 2016    

Forte-centre: Centre for Ageing and Supportive Environments, CASE Investments > €500k Sweden Alzheimer’s disease & other dementias 2016    

Forte-centre Ageing and health: Center for capability in aging (AGECAP) from genes to society Investments > €500k Sweden Alzheimer’s disease & other dementias|Neurodegenerative disease in general 2016    

Programme Grant Care: Living and ageing with cognitive impairments in the technological landscapes of homes and public places Investments > €500k Sweden Alzheimer’s disease & other dementias 2016    

Programme Grant Ageing and health: Mapping and intervening with the behavioral factors influencing cognitive aging Investments > €500k Sweden Alzheimer’s disease & other dementias 2016